A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China

Alzheimer Disease Clinical Trial

— HERITAGE  

Official title:

A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05886114
• Other study ID #: 31005808A111272274170
• Status: Recruiting
• Phase: N/A
• Start date: May 28, 2023
• Est. completion date: April 28, 2027

Study information

• Verified date: June 2023
• Source: Zhejiang University
• Contact: Xin Xu, PhD
• Phone: +8613575760802
• Email: xuxinsummer[@]zju.edu.cn
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A study conducted in Finland discovered that a multidomain intervention, consisting of physical activity, nutritional guidance, cognitive training, social activities, and management of vascular risk factors, effectively decelerated cognitive decline in healthy older adults who were at an increased risk of cognitive decline. The HERITAGE study is a 2-year clustered randomized controlled trial (clustered-RCT) that explores the efficacy of a multidomain intervention among 1200 elderly residents with a higher risk of cognitive decline and dementia in Zhejiang Province, China

Description:

The effectiveness of a multidomain lifestyle intervention on the prevention of cognitive decline and dementia have not been studied in Asian elderly at high risk of dementia conversion. Dementia is caused by both nonmodifiable genetic variables, and modifiable lifestyle risk factors. While neuroimaging biomarkers have been well documented in the neurophysiology of ageing and age-associated cognitive decline, their role as surrogate endpoints and intermediate variables between multi-domain lifestyle intervention and cognitive benefits has not been studied. The current study aims to understand brain functional and structural changes that may result from a multi-domain lifestyle intervention and whether the changes correlate with improvement in cognitive function. At risk elderly aged 60-80 years will be randomly allocated to either the control arm (self-guided management) or the intervention (multi-domain lifestyle) arm, which consists of nutritional guidance, physical exercise, cognitive training and the monitoring and management of vascular and metabolic risk factors. We hypothesize that the multi-domain lifestyle intervention will promote favorable changes in cognitive function. Moreover, such intervention will slow down the progression of cerebrovascular disease and neurodegeneration in participants in the intervention arm. Findings from the present study will shed light on the biological mechanisms of age-related cognitive decline and neurodegenerative disease. Insight obtained from the study could be translated into new targets of nonpharmacological interventions which aim at the potential causal molecular pathways implicated in ageing and age-related cognitive decline. Adaption and implementation of our findings into clinical and public health practice will further promote healthy and confident ageing among Chinese elderly, to eventually expand their health span.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1200
• Est. completion date: April 28, 2027
• Est. primary completion date: April 28, 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 60 Years to 80 Years

Eligibility

Inclusion Criteria:

• At risk of cognitive decline: cognitive performance at the mean level or slightly lower than expected for age with no dementia (AD8>=3 and/or 5-min MoCA >, < 11)

• Free of physical disabilities that preclude participation in the study

• Willing to complete all study-related activities for 24 months

• Willing to be randomized to either lifestyle intervention group

Exclusion Criteria:

• Diagnosed dementia patients

• Diagnosed major depression or other neuropsychological diseases

• Malignant diseases

• Symptomatic cardiovascular disease

• Revascularization within one year

• Severe loss of vision, hearing or communicative ability

Related Conditions & MeSH terms

• Alzheimer Disease
• Brain Diseases
• Central Nervous System Diseases
• Cognition Disorder
• Cognition Disorders
• Cognitive Dysfunction
• Cognitive Impairment
• Mental Disorder
• Mental Disorders
• Nervous System Diseases
• Neurocognitive Disorders
• Vascular Cognitive Impairment

Intervention

Behavioral:
• Structured Multi-domain Intervention
Structured Multi-domain Intervention (SMI) involves providing participants with intensive structure and support by a team of trainers to increase physical exercise, adhere to a healthy diet, cognitive training, increase intellectual/social stimulation, and better manage vascular risk factors.
• Self-Guided Intervention
In the Self-Guided Intervention (SGI), education about the importance of a healthy lifestyle as a preventive strategy and support to encourage change will be provided.

Locations

Country	Name	City	State
China	School of Public Health and The Second Affiliated Hospital of School of Medicine, Zhejiang University, Hangzhou, China	Hangzhou	Zhejiang

Sponsors (1)

Lead Sponsor	Collaborator
Zhejiang University

Country where clinical trial is conducted

China, 

References & Publications (2)

Xu X, Chew KA, Wong ZX, Phua AKS, Chong EJY, Teo CKL, Sathe N, Chooi YC, Chia WPF, Henry CJ, Chew E, Wang M, Maier AB, Kandiah N, Chen CL. The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER): Study Design and Protocol. J Prev Alzheimers Dis. 2022;9(1):40-48. doi: 10.14283/jpad.2022.5. — View Citation

Zhao X, Hu R, Wen H, Xu G, Pang T, He X, Zhang Y, Zhang J, Chen C, Wu X, Xu X. A voice recognition-based digital cognitive screener for dementia detection in the community: Development and validation study. Front Psychiatry. 2022 Jul 22;13:899729. doi: 10 — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Global Cognition	Globe cognitive performance (composite z-score) measured by comprehensive Neuropsychological Test Battery (NTB)	Up to 2 years
Primary	Domain-specific Cognition	NTB domain-specific cognitive performance (composite z-score) for memory, executive function, attention, language, visuomotor speed and visuoconstruction.	Up to 2 years
Secondary	Neuroimaging: MRA	Changes in brain blood flow assessed by magnetic resonance angiography(MRA)	Up to 2 years
Secondary	Neuroimaging: MRI	Changes in brain structural integrity (gray matter volume loss, white matter microstructure degradation and increase of cerebrovascular markers) assessed by T1-weighted Magnetization Prepared Rapid Gradient Recalled Echo, Fluid Attenuated Inversion Recovery (FLAIR), T2-weighted, and Susceptibility Weighted Imaging sequences	Up to 2 years
Secondary	Neuroimaging: fMRI	Changes in brain functional networks assessed by fMRI	Up to 2 years
Secondary	Number of participants with Laboratory Values /Blood markers	Blood samples will be collected from all patients in tubes with ethylenediaminetetraacetic acid 0.1%. Changes in Novel and accessible blood markers to monitor AD- and CeVD- associated pathologies. Plasma concentrations of cardiac markers (High-sensitive cardiac troponin T (hs Troponin T), N-terminal pro b-type natriuretic peptide (NT-proBNP) and Growth/differentiation factor 15 (GDF 15)), and peripheral biomarkers of Aß, tau and synaptic pathology, oxidative stress, endothelial/cardiovascular injury and degenerative protein modifications (DPMs) damaged proteins will be measured by laboratory testings.	Up to 2 years
Secondary	Incident dementia	Incidence of dementia. Dementia diagnoses will be made by CDR and DSM-IV criteria.	Up to 2 years
Secondary	Clinical Dementia Rating-Sum of Boxes (CDR-SB)	The Clinical Dementia Rating-Sum of Boxes (CDR-SB) is scored from 0 to 18. Higher scores reflect worse performance.	Up to 2 years
Secondary	Alzheimer's Disease Cooperative Study Activities of Daily Living Mild Cognitive Impairment-Activities of Daily Living Inventory (ADCS MCI-ADL)	The Alzheimer's Disease Cooperative Study Activities of Daily Living-Mild Cognitive Impairment-Activities of Daily Living Inventory (ADCS MCI-ADL) is scored from 0 to 53. Higher scores reflect better performance.	Up to 2 years
Secondary	Cardiovascular morbidity	Physician-diagnosed cardiometabolic health disorders will be identified based on ICD-9 or ICD-10 codes (in any position). Any incident cardiometabolic morbidity, for example, ardiac dysrhythmias, heart failure, peripheral and visceral atherosclerosis, non-alcoholic fatty liver disease, chronic kidney disease, type 2 diabetes, hypercholesterolemia, and hypertension, will be recorded.	Up to 2 years
Secondary	Physical Performance: Grip strength	Grip strength will be assessed by a hydraulic hand dynamometer and expressed in absolute units(kilograms) andrelative units(kilograms divided by bodyweight).	Up to 2 years
Secondary	Physical Performance: Gaid speed	Walking pace will be assessed by the speed (m/second) of completing a 1.5 meters walk.	Up to 2 years
Secondary	Physical Performance: Balance	Balance will be measured by standing on one foot and expressed in absolute units(seconds).	Up to 2 years
Secondary	Physical Performance: Endurance	Endurance will be assessed by the 2MW. Participants will be asked to "walk as fast as you can without running" for 2 minutes around a 50-foot course. A greater distance(m) indicates better endurance.	Up to 2 years
Secondary	Physical Performance: Lower limb strength	Lower limb strength will be assessed by 30 second sit to stand test and expressed by completion times.	Up to 2 years
Secondary	Quality of Life Questionnaire (15D)	The Quality of Life Questionnaire (15D) has a single index (15D score) on a 0-1 scale, which represents overall HRQoL (0 = being dead, 0.0162 = being unconscious or comatose, 1 = no problems on any dimension = 'full' HRQOL). This is calculated from the health state descriptive system by using a set of population-based preference or utility weights.	Up to 2 years
Secondary	The Geriatric Depression Scale (GDS)	The Geriatric Depression Scale (GDS) is scored from 0 to 15. Scores of 0-4 are considered normal, 5-8 indicate mild depression; 9-11 indicate moderate depression; and 12-15 indicate severe depression.	Up tp 2 years
Secondary	Pittsburgh Sleep Quality Index (PSQI)	The Pittsburgh Sleep Quality Index (PSQI) is scored from 0 to 21. Higher scores indicate worse sleep quality.	Up to 2 years
Secondary	Leisure-Time Activities Questionnaire	The Leisure-Time Activities Questionnaire measures the frequency of engagement in the following activities: Health activities, Social activities, Productive activities, Fitness activities, Recreational activities, Any cognitively-stimulating activities. Scores are measured on a 3-point scale. Higher scores represent higher frequency of engagement in leisure-time activities.	Up to 2 years
Secondary	Resource Use Inventory (RUI)	The Resource Use Inventory (RUI) measures 4 domains: direct medical care, direct nonmedical care, informal care, and subjects' time use. The RUI is filled in based on the frequency and amount of resources used. If none were used, '00' is entered.	Up to 2 years
Secondary	Hight	Height will be measured in metres	Up to 2 years
Secondary	Weight	Weight will be measured in kilograms.	Up to 2 years
Secondary	Hip circumference	Hip circumference will be measured in centimetres.	Up to 2 years
Secondary	Waist circumference	Waist circumference will be measured in centimetres.	Up to 2 years
Secondary	Changes in Blood Pressure	Vascular and metabolic risk factors measured by changes in blood pressure in mmHg. Incident events using serious adverse event reports will also be assessed.	Up to 2 years
Secondary	Changes in lipid Profile	Blood samples will be collected from all patients in tubes with ethylenediaminetetraacetic acid 0.1%. Lipid Profile will be expressed by total cholesterol, LDL-cholesterol, HDL-cholesterol or triglycerides in mmol/L.	Up to 2 years
Secondary	Changes in Glucose Regulation	Vascular and metabolic risk factors measured by changes in glucose regulation in mmol/L.	Up to 2 years
Secondary	Retinal Imaging Markers	Retinal fundus photographs will be taken of each eye with a nonmydriatic digital camera after dilation of pupils with 1% tropicamide eye drops. A semi-automated computer-assisted program will be used to assess retinal vascular fractal dimensions (among other parameters such as vessel caliber and vessel tortuosity) from optic disc-centered images of a randomly selected eye per participant.	Up to 2 years
Secondary	Falls	Prospective rate of falls, causes and consequences via monthly calendar will be recorded.	Up to 2 years